Octagon Therapeutics logo

Octagon Therapeutics

Octagon's discovery platform can identify metabolic targets involved in these cellular adaptations. The company has developed a lead program that has shown activity against the highest priority bacterial “superbugs” in animal efficacy models. The approach has further been applied in targeting specific immunometabolic adaptations in select autoimmune indications. This represents a powerful new platform for identifying new ways to treat these devastating diseases.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttps://www.octagontherapeutics.com
Founded2017
Disease Focus
Development Stage
STOCK CODENon Listed
Address
127 Western Ave, MA 02134
Boston
United States
Email
Contact Number
+1 781 910-8518

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/octagontherapeutics” connections=”true” suffix=””]